201 related articles for article (PubMed ID: 25411995)
1. Evidence of Crohn's disease-related anti-glycoprotein 2 antibodies in patients with celiac disease.
Roggenbuck D; Vermeire S; Hoffman I; Reinhold D; Schierack P; Goihl A; von Arnim U; De Hertogh G; Polymeros D; Bogdanos DP; Bossuyt X
Clin Chem Lab Med; 2015 Aug; 53(9):1349-57. PubMed ID: 25411995
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.
Roggenbuck D; Reinhold D; Wex T; Goihl A; von Arnim U; Malfertheiner P; Büttner T; Porstmann T; Porstmann S; Liedvogel B; Bogdanos DP; Laass MW; Conrad K
Clin Chim Acta; 2011 Apr; 412(9-10):718-24. PubMed ID: 21195704
[TBL] [Abstract][Full Text] [Related]
3. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
Papp M; Sipeki N; Tornai T; Altorjay I; Norman GL; Shums Z; Roggenbuck D; Fechner K; Stöcker W; Antal-Szalmas P; Veres G; Lakatos PL
J Crohns Colitis; 2015 Aug; 9(8):659-68. PubMed ID: 25968583
[TBL] [Abstract][Full Text] [Related]
4. Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.
Laass MW; Röber N; Range U; Noß L; Roggenbuck D; Conrad K
PLoS One; 2015; 10(6):e0128104. PubMed ID: 26047356
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.
Bogdanos DP; Roggenbuck D; Reinhold D; Wex T; Pavlidis P; von Arnim U; Malfertheiner P; Forbes A; Conrad K; Laass MW
BMC Gastroenterol; 2012 Aug; 12():102. PubMed ID: 22866900
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease-specific pancreatic autoantibodies are specifically present in ruminants with paratuberculosis: implications for the pathogenesis of the human disease.
Liaskos C; Spyrou V; Roggenbuck D; Athanasiou LV; Orfanidou T; Mavropoulos A; Reinhold D; Rigopoulou EI; Amiridis GS; Billinis C; Bogdanos DP
Autoimmunity; 2013 Sep; 46(6):388-94. PubMed ID: 23638886
[TBL] [Abstract][Full Text] [Related]
7. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.
Roggenbuck D; Hausdorf G; Martinez-Gamboa L; Reinhold D; Büttner T; Jungblut PR; Porstmann T; Laass MW; Henker J; Büning C; Feist E; Conrad K
Gut; 2009 Dec; 58(12):1620-8. PubMed ID: 19549613
[TBL] [Abstract][Full Text] [Related]
8. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
[TBL] [Abstract][Full Text] [Related]
9. Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn's disease.
Kohoutova D; Drahosova M; Moravkova P; Rejchrt S; Bures J
BMC Gastroenterol; 2014 Dec; 14():190. PubMed ID: 25551469
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease.
Röber N; Noß L; Goihl A; Reinhold D; Jahn J; de Laffolie J; Johannes W; Flemming GM; Roggenbuck D; Conrad K; Laass MW
Inflamm Bowel Dis; 2017 Sep; 23(9):1624-1636. PubMed ID: 28691939
[TBL] [Abstract][Full Text] [Related]
11. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
Kasperkiewicz M; Dähnrich C; Probst C; Komorowski L; Stöcker W; Schlumberger W; Zillikens D; Rose C
J Am Acad Dermatol; 2012 Apr; 66(4):583-8. PubMed ID: 21840083
[TBL] [Abstract][Full Text] [Related]
12. Fully-automated, chemiluminescence IgA and IgG anti-tissue transglutaminase (tTG) antibodies serum assays for the screening of celiac disease.
Daves M; Cemin R; Perkmann V; Bernard P; Caprioli G; Platzgummer S; Lippi G
J Immunol Methods; 2016 Feb; 429():57-9. PubMed ID: 26773454
[TBL] [Abstract][Full Text] [Related]
13. Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
Shpoliansky M; Roggenbuck D; Pinsker M; Salamon N; Weiss B; Shouval DS; Werner L
Dig Dis Sci; 2021 Aug; 66(8):2619-2626. PubMed ID: 32886311
[TBL] [Abstract][Full Text] [Related]
14. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.
de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA
PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980
[TBL] [Abstract][Full Text] [Related]
15. Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease.
Degenhardt F; Dirmeier A; Lopez R; Lang S; Kunst C; Roggenbuck D; Reinhold D; Szymczak S; Rogler G; Klebl F; Franke A; Rieder F
Inflamm Bowel Dis; 2016 Nov; 22(11):2648-2657. PubMed ID: 27753692
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease.
Zhang S; Wu Z; Luo J; Ding X; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Medicine (Baltimore); 2015 Oct; 94(42):e1654. PubMed ID: 26496271
[TBL] [Abstract][Full Text] [Related]
17. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C
Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of serological tests in the diagnosis of celiac disease].
Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
[TBL] [Abstract][Full Text] [Related]
19. Long-standing type 1 diabetes: patients with adult-onset develop celiac-specific immunoreactivity more frequently than patients with childhood-onset diabetes, in a disease duration-dependent manner.
Tiberti C; Panimolle F; Bonamico M; Filardi T; Pallotta L; Nenna R; Pontone S; Dotta F; Pugliese G; Lenzi A; Balducci S; Morano S
Acta Diabetol; 2014 Aug; 51(4):675-8. PubMed ID: 24452477
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
